DXR Stock Analysis: Buy, Sell, or Hold?
DXR - Daxor Corporation Common Stock
$10.00
-0.30 (-2.91%)
▼
5d:
-1.96%
30d:
-4.85%
90d:
+0.5%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Get Alerted When DXR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DXR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DXR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DXR is currently trading at $10.00, which is considered oversold relative to its 30-day fair value range of $10.23 to $10.70.
Technical Outlook: Technically, DXR is showing sideways momentum. The price is currently testing key support at $9.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $22.50 (+125.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DXR is showing sideways momentum. The price is currently testing key support at $9.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $22.50 (+125.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.23 -
$10.70
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 125.0% below Wall St target ($22.50)
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$10.23 -
$10.70
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.95
Resistance Level
$10.48
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-333.33
Wall Street Target
$22.50
(+125.0%)
Revenue Growth (YoY)
-82.6%
Earnings Growth (YoY)
329.3%
Profit Margin
34359.2%
Share & Embed Analysis
Last updated: August 22, 2026 12:40 PM ET
Data refreshes hourly during market hours. Next update: 1:40 PM
Data refreshes hourly during market hours. Next update: 1:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DXR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael Richard Feldschuh
BUY
1000 shares
2026-04-08
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 41 HOLD |
